From: Identification of serum β-catenin as a biomarker in patients with HBV-related liver diseases
Parameter | HC | HHC | CHB | HBLC | HCC |
---|---|---|---|---|---|
Number of subjects | 78 | 41 | 77 | 63 | 61 |
Gender (male, %) | 45 (57.6%) | 29 (70.7%) | 50 (64.9%) | 47 (74.6%) | 39 (63.9%) |
Age (range, mean) | 19–67, 42.1 | 17–59, 39 | 26–66, 45.3 | 32–68, 48.2 | 37–67, 53.5 |
ALT (U/L) | 15.8 ± 7.43 | 16.3 ± 8.33 | 143.8 ± 144.1 | 46.11 ± 41.37 | 16.46 ± 6.56 |
AST (U/L) | 17.98 ± 6.32 | 17.34 ± 7.91 | 173.1 ± 254.5 | 61.52 ± 79.3 | 21.5 ± 7.25 |
HBV DNA (log10 IU/mL) | N/A | 2.58 ± 0.69 | 5 ± 1.65 | 4.96 ± 1.7 | 4.97 ± 2.04 |